The global cell cryopreservation equipment market size is calculated at USD 2.55 billion in 2025 and is predicted to attain around USD 7.37 million by 2035, expanding at a CAGR of 11.2% from 2026 to 2035. The stringent compliances featuring GMP advocacy and rising numbers of commercial-level cell therapies fuel growth in the market. The stem cell-based research and solutions are polishing the market skills.

Cell Cryopreservation Equipment Market Statical Scope

The cell cryopreservation equipment is a robust mechanism featuring biological material that serves as a specialized tools essential for freezing and storing the biological samples. The specialized containers describe the commendable integrity of the container-based materials supporting the cell freezing. The tools serving multiple services of freezing and storing underscore the potential value of the market.

The promising cell therapies and the surge of fine technology and equipment position the market as a complementary aspect to succeed in the patient outcome. The popular IVF is generating more business engagements in the market. The digital tracking and IoT-enabled monitoring are accelerating tech-driven profit in the market.

Cell Cryopreservation Equipment Market Share, By Region, 2025 (%)

• North America – The North America regional segment dominated the market by 41% of share, with the massive clinical trials involving innovations and automation. The extensive use of modern animal-origin-free media and controlled-rate freezing systems is accelerating growth in the regional market.
• Europe – Europe held 30% of the profit with the rising demand for modern cryopreservation. The biobanks are making space in the market for mainly stem cell-based studies and clinical interventions. While the effective investments in R&D are bolstering the regional market.
• Asia-Pacific – Asia Pacific covers 20% of the share due to the vast dominance of the accessories and consumables products. The fine production confirms great revenue for the regional market. The specialized freezing equipment stimulates modern growth in the regional market.
• LAMEA – LAMEA held 9% of profit with the valuable contribution of Mexico, which has stretched its manufacturing potential with North America. This integration doubles the profit of the regional market. The IVF services are another reason for the expansion of the regional market.

Cell Cryopreservation Equipment Market Share, By Product, 2025 (%)

• Consumables/Accessories – The consumables/accessories segment dominated the market by 65% of share, with the growing genetically based treatments encouraging demand for the promising products to justify the potential of cell and gene therapy . The modern technology and materials are the strength of the segmental market.
• Equipment – The equipment covers 35% of the share due to movements in stem cell banking that spur the need for equipment to accomplish the operations. The long-standing storage solutions for clinical trials are elevating the value of the segmental market.

Cell Cryopreservation Equipment Market Share, By Application, 2025 (%)

• Stem Cells – The stem cells segment dominated the market by 32% of share with the rising cancer cases. The cell therapies are like a developmental growth for the segment. While the stem cell repositories and private and public cord blood banks are driving growth in the segmental market.
• Bioproduction Cell Lines – The segment covers 20% of the share, with the demand for therapeutic proteins. This stuns the biologics space with robust performance of the market that spurs more value to the popular CAR-T therapies.
• Reproductive Cells – The reproductive cells rise by 18% of share with the confidence of automated systems and vitrification technology. The extensive applications are promoting assisted reproductive technologies that eventually accelerate the segmental market.
• Primary Cells – The segment held 16% of the share, with the strength of regenerative medicine featuring popular stem cells. The automated controlled-rate freezers are effective to source of profit for the market's potential.

Cell Cryopreservation Equipment Market Share, By End-use, 2025 (%)

• Biopharmaceutical and Pharmaceutical Companies – The biopharmaceutical and pharmaceutical companies dominated the market by 37% of share with the fine expansion of biologics and cell therapy . The smart storage systems and tech integration bolster the market.
• Academic and Research Institutes – The segment covers 22% of the share with the perk of modern CRFs, real-time monitoring and automated storage systems. The traffic in cancer research is promoting the core benefits of the market.
• Biobanks – Biobanks held 18% of the share, with the popular stem cell research dominance that drives expansion to modern equipment. The long-standing storage justifies the expansion of the biobanks in the market. The gene therapies and cell-related research unlock the important potential of the segment.
• IVF Clinics – The segment covers 15% of the market share with the advancements, benefits like modern cryopreservation media. The advanced clinics and AI-inspired monitoring are driving modernized growth in the segment.

Top Companies in the Cell Cryopreservation Equipment Market

• Thermo Fisher Scientific Inc.
• Azenta US Inc.
• MVE Biological Solutions.
• INOXCVA
• Haier Biomedical
• Kirsch GmbH
• Planer, a Hamilton Thorne company
• Eppendorf SE
• Labtron Equipment Ltd.
  

Segments Covered in the Report

By Product

• Equipment
  • Freezers
  • Liquid Nitrogen Supply Tanks
  • Incubators
• Consumables/Accessories
  • Cryogenic vials
  • Cryogenic tubes
  • Cooler boxes/containers
  • Others

By Application

• Stem Cells
• Reproductive Cells
• Bioproduction Cell Lines
• Primary Cells
• Others

By End Use

• Biopharmaceutical & Pharmaceutical Companies
• Academic and Research Institutes
• Biobanks
• IVF clinics
• Others

By Regional

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait